About the organization
Basic details : 3CTN is the only Canadian network of cancer centres that provides core funding support for institutions, investigators, and trials teams to conduct multi-centre, academic cancer clinical trials (ACCTs) on its Portfolio as well as incentive funding to support accrual. In addition to funding, 3CTN facilitates new trial development, ensures best practice standards for trial management, and supports initiatives to improve performance and address challenges within the clinical trial environment.
The overarching aim is to ensure that Canada continues as a world leader in cancer clinical trials, there are increased opportunities for patients to receive promising new treatments, and that cancer outcomes continue to improve through the conduct of ACCTs.
From its origins, patient and public involvement has been integrated within all areas of Network governance including recent development of a growing Patient Representative Community of Practice comprised of patient partners in clinical research being conducted at sites.
Mission : To ensure access to, and efficient execution of academic cancer clinical trials across the pan-Canadian network of Cancer Centres.
Vision : Canadians will have access to the best available cancer treatments through successful execution of academic clinical trials.
Organization primary focus : Supporting and improving the peformance of academic cancer clinical trials
Structure : Clinical trial units staff (Investigators, clinical research professionals) and patient partners within 39 adult and 17 pediatric cancer centres across Canada.
Affiliation : 3CTN is funded by provincial agencies within each member province as well as nationally by the Canadian Partnership Against Cancer (CPAC)
Website
Address
661 University Avenue, Suite 510 M5G 0A3 Toronto, Canada
Contact us for
General partnerships, Good practice sharing, Opportunities for patient engagement collaborations, Speaking opportunities
Organization main contact email
info@3ctn.ca
Phone number
1-866-678-6427
People
Stephen Sundquist
3CTN - Canadian Cancer Clinical Trials Network
Toronto, Canada